# Treatment for Adolescents With Depression Study (TADS)

> **NCT00006286** · PHASE3 · COMPLETED · sponsor: **National Institute of Mental Health (NIMH)** · enrollment: 432 (—)

## Conditions studied

- Major Depressive Disorder
- Depression

## Interventions

- **DRUG:** Fluoxetine
- **BEHAVIORAL:** Psychotherapy

## Key facts

- **NCT ID:** NCT00006286
- **Lead sponsor:** National Institute of Mental Health (NIMH)
- **Sponsor class:** NIH
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 1998-09
- **Primary completion:** —
- **Final completion:** 2004-03
- **Target enrollment:** 432 (—)
- **Last updated:** 2014-04-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00006286

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00006286, "Treatment for Adolescents With Depression Study (TADS)". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT00006286. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*